These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20447217)

  • 1. Smokeless tobacco products: Unrecognised regulatory and policy opportunities.
    Gartner CE; Hall WD
    Drug Alcohol Rev; 2010 Mar; 29(2):119-20. PubMed ID: 20447217
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scientific basis of tobacco product regulation.
    Ashley DL; Burns D; Djordjevic M; Dybing E; Gray N; Hammond SK; Henningfield J; Jarvis M; Reddy KS; Robertson C; Zaatari G;
    World Health Organ Tech Rep Ser; 2008; (951):1-277, 1 p following 277. PubMed ID: 19522165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. South Africa: snus "not a tobacco product".
    Saloojee Y
    Tob Control; 2008 Feb; 17(1):2-3. PubMed ID: 18218790
    [No Abstract]   [Full Text] [Related]  

  • 8. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whither tobacco product regulation?
    McNeill A; Hammond D; Gartner C
    Tob Control; 2012 Mar; 21(2):221-6. PubMed ID: 22345253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages.
    Callery WE; Hammond D; O'Connor RJ; Fong GT
    Nicotine Tob Res; 2011 May; 13(5):373-83. PubMed ID: 21357730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of snus products within a tobacco harm reduction strategy.
    Patwardhan S
    J Public Health (Oxf); 2009 Jun; 31(2):310-1; author reply 311. PubMed ID: 19282332
    [No Abstract]   [Full Text] [Related]  

  • 13. Standard tobacco packaging still being considered but is not a "silver bullet," says health department.
    O'Dowd A
    BMJ; 2013 Nov; 347():f6751. PubMed ID: 24212470
    [No Abstract]   [Full Text] [Related]  

  • 14. The case for the plain packaging of tobacco products.
    Freeman B; Chapman S; Rimmer M
    Addiction; 2008 Apr; 103(4):580-90. PubMed ID: 18339104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing smokeless tobacco products new tobacco-delivery systems.
    Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.
    Ayo-Yusuf OA; Burns DM
    Tob Control; 2012 Mar; 21(2):245-51. PubMed ID: 22345261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts.
    Levy DT; Mumford EA; Cummings KM; Gilpin EA; Giovino G; Hyland A; Sweanor D; Warner KE
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2035-42. PubMed ID: 15598758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco industry interference for pictorial warnings.
    Oswal KC; Pednekar MS; Gupta PC
    Indian J Cancer; 2010 Jul; 47 Suppl 1():101-4. PubMed ID: 20622423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.